Identitet

(2S,6S)-2-Amino-2-(2-chlorophenyl)-6-hydroxycyclohexanone

Ikke angivet · C12H14ClNO2

01Identitet

Lazychem IDLC-38211
CAS RNIkke angivet
PubChem CID71519584
Molecular formulaC12H14ClNO2
Molecular weight239.70 g/mol
IUPAC namecis-(2S,6S)-2-amino-2-(2-chlorophenyl)-6-hydroxycyclohexan-1-one
InChIKeyCFBVGSWSOJBYGC-JQWIXIFHSA-N

02Struktur og stereokemi

Two-dimensional chemical structure of (2S,6S)-2-Amino-2-(2-chlorophenyl)-6-hydroxycyclohexanone
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 2 rings, includes aromatic atoms, includes aliphatic carbon, has 2 defined stereocentres, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres2
Ring count2
Secondary amines0
Tertiary amines0
SMILESC1C[C@@H](C(=O)[C@](C1)(C2=CC=CC=C2Cl)N)O
InChIIkke angivet

03Stereochemistry

The published structure contains 2 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres2Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 4Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status i Indien

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Navne og relationer

API og moderlægemiddel

Ikke angivet

Navne og relationer

    06Kilder